You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The report advises that although sequencing the genomes of infants can be appropriate in some specific cases, we shouldn’t implement large-scale programs to test healthy babies.
Testing with Cepheid's molecular TB assay can shorten the amount of time suspected patients need to be isolated and save thousands of dollars per patient.
In Science this week: genetic and epidemiological study tracking recent Brazilian yellow fever outbreak, and more.
The firm said it will use the funds to build its IP portfolio, expand its team, and develop an infrastructure for partners to build on its CRISPR platform.
In Cell this week: structural variants affecting regulatory loci in prostate cancer, immune features in the breast cancer microenvironment, and more.
A new paper critiques the analysis and conclusions of the Atacama mummy genome sequencing study.
The researchers said their method for mapping genetic interactions can serve as a blueprint for mapping the genetic landscape of human cells.
One study characterized an allele linked to aggressive prostate cancer, while the other explored the range of structural variations within metastatic disease.
CNBC reports that there are thousands of genetic tests available for consumers to chose between.
Researchers have developed a way to quickly edit white blood cells, according to the New York Times.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.